JP2025501141A5 - - Google Patents
Info
- Publication number
- JP2025501141A5 JP2025501141A5 JP2024538669A JP2024538669A JP2025501141A5 JP 2025501141 A5 JP2025501141 A5 JP 2025501141A5 JP 2024538669 A JP2024538669 A JP 2024538669A JP 2024538669 A JP2024538669 A JP 2024538669A JP 2025501141 A5 JP2025501141 A5 JP 2025501141A5
- Authority
- JP
- Japan
- Prior art keywords
- heterocycloalkyl
- alkylene
- cycloalkyl
- heteroaryl
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2021904268 | 2021-12-24 | ||
| AU2021904268A AU2021904268A0 (en) | 2021-12-24 | Compounds | |
| PCT/AU2022/051591 WO2023115165A1 (en) | 2021-12-24 | 2022-12-23 | Compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025501141A JP2025501141A (ja) | 2025-01-17 |
| JP2025501141A5 true JP2025501141A5 (enExample) | 2026-01-08 |
Family
ID=86900872
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024538669A Pending JP2025501141A (ja) | 2021-12-24 | 2022-12-23 | 化合物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250163044A1 (enExample) |
| EP (1) | EP4452979A4 (enExample) |
| JP (1) | JP2025501141A (enExample) |
| KR (1) | KR20240128059A (enExample) |
| CN (1) | CN118974044A (enExample) |
| AU (1) | AU2022422215A1 (enExample) |
| CA (1) | CA3241845A1 (enExample) |
| IL (1) | IL313857A (enExample) |
| MX (1) | MX2024007911A (enExample) |
| WO (1) | WO2023115165A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3519816A4 (en) | 2016-09-29 | 2020-05-06 | The Regents of the University of California | CONNECTIONS FOR INCREASING NEURONAL PLASTICITY |
| KR102946120B1 (ko) | 2019-02-27 | 2026-03-30 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 뇌 장애를 치료하기 위한 아제피노-인돌 및 다른 헤테로사이클 |
| WO2021226416A1 (en) | 2020-05-08 | 2021-11-11 | Psilera Inc. | Novel compositions of matter and pharmaceutical compositions |
| EP4255422A4 (en) * | 2020-12-03 | 2024-12-18 | Mydecine Innovations Group Inc. | NEW PSILOCIN ANALOGUE COMPOSITIONS AND METHODS OF THEIR SYNTHESIS |
| KR20240058859A (ko) | 2021-08-12 | 2024-05-03 | 쿨레온 엘엘씨 | 환각성 및 비환각성 세로토닌 수용체 작용제 및 이의 제조 및 사용 방법 |
| IL313455A (en) | 2021-12-15 | 2024-08-01 | Delix Therapeutics Inc | Phenoxy and benzyloxy modified psychroplastogens and their uses |
| WO2023129956A2 (en) | 2021-12-30 | 2023-07-06 | ATAI Life Sciences AG | Dimethyltryptamine analogues as nitric oxide delivery drugs |
| WO2025000053A1 (en) * | 2023-06-28 | 2025-01-02 | Psylo Pty Ltd | Compounds |
| WO2025000051A1 (en) | 2023-06-28 | 2025-01-02 | Psylo Pty Ltd | Pyrrolopyridine compounds for the treatment of mental illnesses |
| WO2026030052A1 (en) | 2024-07-31 | 2026-02-05 | Fmc Corporation | Fungicidal substituted azoles |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5977131A (en) * | 1997-04-09 | 1999-11-02 | Pfizer Inc. | Azaindole-ethylamine derivatives as nicotinic acetylcholine receptor binding agents |
| GB9819020D0 (en) * | 1998-09-01 | 1998-10-28 | Cerebrus Ltd | Chemical compounds III |
| EP1132389A1 (en) * | 2000-03-06 | 2001-09-12 | Vernalis Research Limited | New aza-indolyl derivatives for the treatment of obesity |
| MXPA04011791A (es) * | 2002-05-30 | 2005-07-26 | Jesse A May | Piranoindazoles y su uso para el tratamiento de glaucoma. |
| US7964728B2 (en) * | 2006-07-06 | 2011-06-21 | Solvay Pharmaceuticals B.V. | Azaindole derivatives with a combination of partial nicotinic acetyl-choline receptor agonism and dopamine reuptake inhibition |
| IL266563B (en) * | 2009-10-06 | 2022-09-01 | Millennium Pharm Inc | Heterocyclic compounds useful as pdk1 inhibitors |
| EP2771341A4 (en) * | 2011-10-28 | 2015-09-23 | Univ Texas | NEW COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER |
| KR20230066311A (ko) * | 2020-06-10 | 2023-05-15 | 델릭스 테라퓨틱스, 인크. | 삼환형 사이코플라스토겐 및 이의 용도 |
| EP4255422A4 (en) * | 2020-12-03 | 2024-12-18 | Mydecine Innovations Group Inc. | NEW PSILOCIN ANALOGUE COMPOSITIONS AND METHODS OF THEIR SYNTHESIS |
| KR20240058859A (ko) | 2021-08-12 | 2024-05-03 | 쿨레온 엘엘씨 | 환각성 및 비환각성 세로토닌 수용체 작용제 및 이의 제조 및 사용 방법 |
-
2022
- 2022-12-23 CN CN202280091203.9A patent/CN118974044A/zh active Pending
- 2022-12-23 MX MX2024007911A patent/MX2024007911A/es unknown
- 2022-12-23 IL IL313857A patent/IL313857A/en unknown
- 2022-12-23 US US18/722,007 patent/US20250163044A1/en active Pending
- 2022-12-23 KR KR1020247024904A patent/KR20240128059A/ko active Pending
- 2022-12-23 WO PCT/AU2022/051591 patent/WO2023115165A1/en not_active Ceased
- 2022-12-23 JP JP2024538669A patent/JP2025501141A/ja active Pending
- 2022-12-23 CA CA3241845A patent/CA3241845A1/en active Pending
- 2022-12-23 EP EP22908927.1A patent/EP4452979A4/en active Pending
- 2022-12-23 AU AU2022422215A patent/AU2022422215A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025501141A5 (enExample) | ||
| JP2025501630A5 (enExample) | ||
| JP2025501629A5 (enExample) | ||
| JP7664201B2 (ja) | アミロイド標的剤及びその使用方法 | |
| US11459327B1 (en) | Cycloalkyl and hetero-cycloalkyl inhibitors, preparation methods therefor, and use thereof | |
| US12145935B2 (en) | Inhibitors of (α-v)(β-6) integrin | |
| US12552786B2 (en) | Inhibitors of αvβ6 integrin | |
| CN110963994B (zh) | 异吲哚啉类化合物、其制备方法、药物组合物及用途 | |
| CN108366996B (zh) | 四氢-1H-吡啶[3,4-b]吲哚类抗雌激素药物 | |
| TWI798470B (zh) | 作為神經激肽－１受體拮抗劑的化合物及其用途 | |
| US20160272654A1 (en) | Spirocyclic dihydro-thiazine and dihydro-oxazine bace inhibitors, and compositions and uses thereof | |
| BG98870A (bg) | /(бензодиоксан,бензофуран или бензопиран)-алкиламино/ алкилзаместени гуанидини като селективни съдосвиващи средства | |
| CA3082948A1 (en) | Novel bradykinin b2 receptor antagonists | |
| JP6830991B2 (ja) | 緑内障および高眼圧症を治療するためのプロスタグランジン複合体および誘導体 | |
| JP5009151B2 (ja) | Ｂｃｒｐ／ａｂｃｇ２阻害剤 | |
| CN110156656B (zh) | 五元杂芳环衍生物、其制备方法、药物组合物及应用 | |
| UA100192C2 (en) | 1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands | |
| JP2024534572A5 (enExample) | ||
| JP2025081626A (ja) | ペンタミジンの類似体及びその使用 | |
| JP2019521964A5 (enExample) | ||
| WO2019224667A1 (en) | Indanes as nrf2 activators | |
| TWI641584B (zh) | α－取代甘胺醯胺衍生物 | |
| EA027882B1 (ru) | Этинильные производные в качестве антагонистов метаботропного глутаматного рецептора | |
| JP6712331B2 (ja) | Ｊａｋ阻害剤としてのピラゾリルアミノベンズイミダゾール誘導体 | |
| JPWO2019059344A1 (ja) | 化学活性化型水溶性プロドラッグ |